Conditions: Epilepsy
Keywords: Epilepsy seizure clusters acute repetitive seizures rescue treatment
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 62
Healthy volunteers: no

Brief summary:
This study is designed to evaluate the efficacy, safety, and tolerability of USL261 compared with that of intranasal (IN) placebo for the treatment of intermittent bouts of increased seizure activity.

Detailed description:

Arms:
arm 1: 5 mg intranasal midazolam arm 2: intranasal placebo

Interventions: intervention 1: USL261 intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: